Vascular Closure Device Market Size & Share Report, 2032

Vascular Closure Device Market – By Device Type (Active [Suture-Mediated, Staple Clips-Mediated, Collagen Plug-Mediated], Passive [Haemostasis Pads/Patches, Compression Devices]), Access (Femoral, Radial), End-use (Hospitals) & Forecast, 2024 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Research design

1.2.1&nbsp;&nbsp;&nbsp; Research approach

1.2.2&nbsp;&nbsp;&nbsp; Data collection methods

1.3&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3.1&nbsp;&nbsp;&nbsp; Base year calculation

1.3.2&nbsp;&nbsp;&nbsp; Key trends for market estimation

1.4&nbsp;&nbsp;&nbsp; Forecast model

1.5&nbsp;&nbsp;&nbsp; Primary research and validation

1.5.1&nbsp;&nbsp;&nbsp; Primary sources

1.5.2&nbsp;&nbsp;&nbsp; Data mining sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Increasing number of patients suffering from cardiovascular diseases

3.2.1.2&nbsp;&nbsp;&nbsp; Growing geriatric population

3.2.1.3&nbsp;&nbsp;&nbsp; Technological advancements in vascular closure devices

3.2.1.4&nbsp;&nbsp;&nbsp; Rising popularity of minimally invasive procedures

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; High risk associated with post-procedural complications

3.2.2.2&nbsp;&nbsp;&nbsp; Stringent regulatory scenario

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Technology landscape

3.6&nbsp;&nbsp;&nbsp; Vascular closure device market, 2021-2032 (Units)

3.6.1&nbsp;&nbsp;&nbsp; North America

3.6.2&nbsp;&nbsp;&nbsp; Europe

3.6.3&nbsp;&nbsp;&nbsp; Asia Pacific

3.6.4&nbsp;&nbsp;&nbsp; Latin America

3.6.5&nbsp;&nbsp;&nbsp; Middle East &amp; Africa

3.7&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

3.9&nbsp;&nbsp;&nbsp; Future market trends

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Company market share analysis

4.4&nbsp;&nbsp;&nbsp; Competitive analysis of major market players

4.5&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.6&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Device Type, 2021 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Active vascular closure devices

5.2.1&nbsp;&nbsp;&nbsp; Suture-mediated devices

5.2.2&nbsp;&nbsp;&nbsp; Staple clips-mediated vascular closure devices

5.2.3&nbsp;&nbsp;&nbsp; Collagen plug-mediated devices

5.3&nbsp;&nbsp;&nbsp; Passive vascular closure devices

5.3.1&nbsp;&nbsp;&nbsp; Haemostasis pads/patches

5.3.2&nbsp;&nbsp;&nbsp; Compression devices

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Access, 2021 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Femoral

6.3&nbsp;&nbsp;&nbsp; Radial

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-Use, 2021 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Hospitals

7.3&nbsp;&nbsp;&nbsp; Ambulatory surgical centers

7.4&nbsp;&nbsp;&nbsp; Other end-users

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2021 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; North America

8.2.1&nbsp;&nbsp;&nbsp; U.S.

8.2.2&nbsp;&nbsp;&nbsp; Canada

8.3&nbsp;&nbsp;&nbsp; Europe

8.3.1&nbsp;&nbsp;&nbsp; Germany

8.3.2&nbsp;&nbsp;&nbsp; UK

8.3.3&nbsp;&nbsp;&nbsp; France

8.3.4&nbsp;&nbsp;&nbsp; Spain

8.3.5&nbsp;&nbsp;&nbsp; Italy

8.3.6&nbsp;&nbsp;&nbsp; Poland

8.3.7&nbsp;&nbsp;&nbsp; Sweden

8.3.8&nbsp;&nbsp;&nbsp; Netherlands

8.3.9&nbsp;&nbsp;&nbsp; Rest of Europe

8.4&nbsp;&nbsp;&nbsp; Asia Pacific

8.4.1&nbsp;&nbsp;&nbsp; China

8.4.2&nbsp;&nbsp;&nbsp; Japan

8.4.3&nbsp;&nbsp;&nbsp; India

8.4.4&nbsp;&nbsp;&nbsp; Australia

8.4.5&nbsp;&nbsp;&nbsp; South Korea

8.4.6&nbsp;&nbsp;&nbsp; Indonesia

8.4.7&nbsp;&nbsp;&nbsp; Philippines

8.4.8&nbsp;&nbsp;&nbsp; Vietnam

8.4.9&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

8.5&nbsp;&nbsp;&nbsp; Latin America

8.5.1&nbsp;&nbsp;&nbsp; Brazil

8.5.2&nbsp;&nbsp;&nbsp; Mexico

8.5.3&nbsp;&nbsp;&nbsp; Argentina

8.5.4&nbsp;&nbsp;&nbsp; Colombia

8.5.5&nbsp;&nbsp;&nbsp; Chile

8.5.6&nbsp;&nbsp;&nbsp; Peru

8.5.7&nbsp;&nbsp;&nbsp; Rest of Latin America

8.6&nbsp;&nbsp;&nbsp; Middle East and Africa

8.6.1&nbsp;&nbsp;&nbsp; South Africa

8.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

8.6.3&nbsp;&nbsp;&nbsp; UAE

8.6.4&nbsp;&nbsp;&nbsp; Turkey

8.6.5&nbsp;&nbsp;&nbsp; Israel

8.6.6&nbsp;&nbsp;&nbsp; Iran

8.6.7&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

9.2&nbsp;&nbsp;&nbsp; Advanced Vascular Dynamics

9.3&nbsp;&nbsp;&nbsp; Biotronik SE &amp; Co. KG

9.4&nbsp;&nbsp;&nbsp; Cardinal Health, Inc.

9.5&nbsp;&nbsp;&nbsp; Ensite Vascular

9.6&nbsp;&nbsp;&nbsp; Haemonetics Corporation (cardiva Medical Inc.)

9.7&nbsp;&nbsp;&nbsp; Marine Polymer Technologies

9.8&nbsp;&nbsp;&nbsp; Medtronic, Plc

9.9&nbsp;&nbsp;&nbsp; Merit Medical Systems

9.10&nbsp;&nbsp;&nbsp; REX MEDICAL

9.11&nbsp;&nbsp;&nbsp; Teleflex Incorporated

9.12&nbsp;&nbsp;&nbsp; Terumo Corporation

9.13&nbsp;&nbsp;&nbsp; Tricol Biomedical

9.14&nbsp;&nbsp;&nbsp; TZ Medical

9.15&nbsp;&nbsp;&nbsp; Vasorum Limited 
&nbsp;

Vascular Closure Device Market

Get a free sample of this report

Industries

Information

Link

Global Headquarters